0001209191-20-038169.txt : 20200622
0001209191-20-038169.hdr.sgml : 20200622
20200622162213
ACCESSION NUMBER: 0001209191-20-038169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200610
FILED AS OF DATE: 20200622
DATE AS OF CHANGE: 20200622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bass James Edward
CENTRAL INDEX KEY: 0001662321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 20979094
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-10
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662321
Bass James Edward
5320 LEGACY DR.
PLANO
TX
75024
1
0
0
0
Stock Option (right to buy)
130.92
2020-06-10
4
A
0
6300
0.00
A
2030-06-10
Class A common stock
6300
6300
D
Stock Option (right to buy)
130.92
2020-06-10
4
A
0
821
82.15
A
2030-06-10
Class A common stock
821
821
D
The options vest in 4 equal installments on September 10, 2020, December 10, 2020, March 10, 2021, and June 10, 2021, subject to continued service through each vesting date.
The options vest in the following installments: 205 shares on September 10, 2020, December 10, 2020 and March 10, 2021, respectively, and 206 shares on June 10, 2021, subject to continued service through each vesting date.
This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $67,500.
/s/ Tracy Herson, attorney-in-fact
2020-06-22